A report published Friday by Vermont Senator Bernie Sanders, the ranking member of the Senate Health, Education, Labor and ...
Researchers analyze prostate cancer incidence over 20 years in men aged 45-70 years without prostate cancer and identify ...
Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.
This year, the Grammy Awards did more than deliver star‑studded performances: It delivered hope. At Crypto.com Arena in Los ...
A lab on Harvard campus that made real progress in diagramming each stage of the disease had its $7M grant pulled. The funding was eventually restored but not in time for the next round of research.
In a sharp rebuke to the Trump administration’s campaign to slash medical research, Congress passed legislation Tuesday that ...
The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...
Oklahoma puts its tobacco settlement funds in a trust, spending only the interest. The strategy has had long-term public ...
Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...
It had broad bipartisan support but passage still required years of heartbreaking lobbying by extraordinarily dedicated ...
Across the United States, the future of federal funding for cancer research is uncertain. President Donald Trump has proposed ...
The sBLA is supported by results from the pivotal phase 3 TROPION-Breast02 clinical trial (NCT05374512), which evaluated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results